FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Laure Aurelian

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Phenomena

Co-author Network

Publications

TOP 3
Gorgun Akpek; Bhavana Bhatnagar; Canan Günay; Ranjit Joseph; Irving I Kessler; Marianna Shvartsbeyn; Laure Aurelian
Frequent detection of herpes simplex virus antigen in skin and peripheral blood CD34+ mononuclear cells from patients with graft-versus-host disease.
Mo Guan; Xiaoqing Liu; Yuan Liu; Haoran Peng; Hao Ren; Yimin Tong; Wenbo Wang; Ping Zhao; Shiying Zhu; Y Zhu; Laure Aurelian; Thomas F Baumert; Jean Dubuisson; Zhongtian Qi
Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.
Laure Aurelian; Jennifer M Laing; Ki Seok Lee
H11/HspB8 and Its Herpes Simplex Virus Type 2 Homologue ICP10PK Share Functions That Regulate Cell Life/Death Decisions and Human Disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Laure Aurelian (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gorgun Akpek; Bhavana Bhatnagar; Canan Günay; Ranjit Joseph; Irving I Kessler; Marianna Shvartsbeyn; Laure Aurelian
Frequent detection of herpes simplex virus antigen in skin and peripheral blood CD34+ mononuclear cells from patients with graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(4):529-37.
2012: Mo Guan; Xiaoqing Liu; Yuan Liu; Haoran Peng; Hao Ren; Yimin Tong; Wenbo Wang; Ping Zhao; Shiying Zhu; Y Zhu; Laure Aurelian; Thomas F Baumert; Jean Dubuisson; Zhongtian Qi
Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.
The Journal of biological chemistry 2012;287(42):35631-45.
2012: Laure Aurelian; Jennifer M Laing; Ki Seok Lee
H11/HspB8 and Its Herpes Simplex Virus Type 2 Homologue ICP10PK Share Functions That Regulate Cell Life/Death Decisions and Human Disease.
Autoimmune diseases 2012;2012():395329.
2012: Cynthia C Smith; J Hersl; J M Laing; K S Lee; B Li; Marianna Shvartsbeyn; Laure Aurelian
Restored expression of the atypical heat shock protein H11/HspB8 inhibits the growth of genetically diverse melanoma tumors through activation of novel TAK1-dependent death pathways.
Cell death & disease 2012;3():e371.
2011: Cynthia C Smith; Kie-Sok Lee; Baiquan Li; Juan Liu; Laure Aurelian
The Levels of H11/HspB8 DNA methylation in human melanoma tissues and xenografts are a critical molecular marker for 5-Aza-2'-deoxycytidine therapy.
Cancer investigation 2011;29(6):383-95.
2011: Juan Liu; Andrew R Yang; Timothy Kelly; Adam C Puche; Chioma Esoga; Harry L June; Ahmed Elnabawi; Istvan Merchenthaler; Werner Sieghart; Harry L June; Laure Aurelian
Binge alcohol drinking is associated with GABAA alpha2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(11):4465-70.
2011: Andrew R S T Yang; Heon S Yi; Laure Aurelian; Ahmed Elnabawi; Harry L June; Juan Liu; Adam C Puche; Werner Sieghart; Mingfei Wang; Kaitlin T Warnock; Harry L June
Binge Drinking: In Search of its Molecular Target via the GABA(A) Receptor.
Frontiers in neuroscience 2011;5():123.
2010: Aric Colunga; Jennifer M Laing; Laure Aurelian
The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.
Gene therapy 2010;17(3):315-27.
2010: Jennifer M Laing; Cynthia C Smith; Laure Aurelian
Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine.
Journal of neurochemistry 2010;112(3):662-76.
2008: Samantha Q Wales; Jennifer M Laing; Ling Chen; Laure Aurelian
ICP10PK inhibits calpain-dependent release of apoptosis-inducing factor and programmed cell death in response to the toxin MPP+.
Gene therapy 2008;15(20):1397-409.
2008: Joseph W Burnett; Jennifer M Laing; Laure Aurelian
Acute skin eruptions that are positive for herpes simplex virus DNA polymerase in patients with stem cell transplantation: a new manifestation within the erythema multiforme reactive dermatoses.
Archives of dermatology 2008;144(7):902-7.
2008: Jennifer M Laing; Erin K Golembewski; Samantha Q Wales; Juan Liu; M Samir Jafri; Paul J Yarowsky; Laure Aurelian
Growth-compromised HSV-2 vector Delta RR protects from N-methyl-D-aspartate-induced neuronal degeneration through redundant activation of the MEK/ERK and PI3-K/Akt survival pathways, either one of which overrides apoptotic cascades.
Journal of neuroscience research 2008;86(2):378-91.
2008: Jennifer M Laing; Laure Aurelian
DeltaRR vaccination protects from KA-induced seizures and neuronal loss through ICP10PK-mediated modulation of the neuronal-microglial axis.
Genetic vaccines and therapy 2008;6():1.
2007: Samantha Q Wales; Baiquan Li; Jennifer M Laing; Laure Aurelian
The herpes simplex virus type 2 gene ICP10PK protects from apoptosis caused by nerve growth factor deprivation through inhibition of caspase-3 activation and XIAP up-regulation.
Journal of neurochemistry 2007;103(1):365-79.
2007: B Li; Cynthia C Smith; Jennifer M Laing; Michael D Gober; L Liu; Laure Aurelian
Overload of the heat-shock protein H11/HspB8 triggers melanoma cell apoptosis through activation of transforming growth factor-beta-activated kinase 1.
Oncogene 2007;26(24):3521-31.
2007: Erin K Golembewski; Samantha Q Wales; Laure Aurelian; Paul J Yarowsky
The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity.
Experimental neurology 2007;203(2):381-93.
2007: Michael D Gober; Jennifer M Laing; Joseph W Burnett; Laure Aurelian
The Herpes simplex virus gene Pol expressed in herpes-associated erythema multiforme lesions upregulates/activates SP1 and inflammatory cytokines.
Dermatology (Basel, Switzerland) 2007;215(2):97-106.
2006: Michael D Gober; Jennifer M Laing; Scott M Thompson; Laure Aurelian
The growth compromised HSV-2 mutant DeltaRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures.
Brain research 2006;1119(1):26-39.
2006: Jennifer M Laing; Michael D Gober; Erin K Golembewski; Scott M Thompson; Kymberly A Gyure; Paul J Yarowsky; Laure Aurelian
Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;13(5):870-81.
2006: Bhuvnesh K Sharma; Cynthia C Smith; Jennifer M Laing; Dakara A Rucker; Joseph W Burnett; Laure Aurelian
Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions.
Dermatology (Basel, Switzerland) 2006;213(3):192-9.
2005: Michael D Gober; Samantha Q Wales; J Colin Hunter; Bhuvnesh K Sharma; Laure Aurelian
Stress up-regulates neuronal expression of the herpes simplex virus type 2 large subunit of ribonucleotide reductase (R1; ICP10) by activating activator protein 1.
Journal of neurovirology 2005;11(4):329-36.
2005: Fumitake Ono; Bhuvnesh K Sharma; Cynthia C Smith; Joseph W Burnett; Laure Aurelian
CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM).
The Journal of investigative dermatology 2005;124(6):1215-24.
2005: Michael D Gober; Samantha Q Wales; Laure Aurelian
Herpes simplex virus type 2 encodes a heat shock protein homologue with apoptosis regulatory functions.
Frontiers in bioscience : a journal and virtual library 2005;10():2788-803.
2005: Laure Aurelian
Cross talk of signaling and apoptotic cascades in the CNS: target for virus modulation.
Frontiers in bioscience : a journal and virtual library 2005;10():2776-87.
2005: Laure Aurelian
HSV-induced apoptosis in herpes encephalitis.
Current topics in microbiology and immunology 2005;289():79-111.
2004: Michael D Gober; C Depre; Laure Aurelian
Correspondence regarding M.V. Kim et al. "Some properties of human small heat shock protein Hsp22 (H11 or HspB8)".
Biochemical and biophysical research communications 2004;321(2):267-8.
2004: Laure Aurelian
Herpes simplex virus type 2 vaccines: new ground for optimism?
Clinical and diagnostic laboratory immunology 2004;11(3):437-45.
2004: Samantha Q Wales; Cynthia C Smith; M Wachsman; G Calton; Laure Aurelian
Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.
Clinical and diagnostic laboratory immunology 2004;11(1):42-9.
2003: Michael D Gober; Cynthia C Smith; Kaori Ueda; Jeffrey A Toretsky; Laure Aurelian
Forced expression of the H11 heat shock protein can be regulated by DNA methylation and trigger apoptosis in human cells.
The Journal of biological chemistry 2003;278(39):37600-9.
2003: Laure Aurelian; F Ono; Joseph W Burnett
Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component.
Dermatology online journal 2003;9(1):1.
2003: Dana Perkins; Kymberly A Gyure; Edna F R Pereira; Laure Aurelian
Herpes simplex virus type 1-induced encephalitis has an apoptotic component associated with activation of c-Jun N-terminal kinase.
Journal of neurovirology 2003;9(1):101-11.
2003: Dana Perkins; Edna F R Pereira; Laure Aurelian
The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1.
Journal of virology 2003;77(2):1292-305.
2002: Antônio J R da Silva; Camilla D Buarque; Flávia V Brito; Laure Aurelian; Luciana Macedo; Linda H Malkas; Robert Hickey; Daniele V S Lopes; François Noël; Yugo L B Murakami; Noelson M V Silva; Paulo A Melo; Rodrigo R B Caruso; Newton G Castro; Paulo R R Costa
Synthesis and preliminary pharmacological evaluation of new (+/-) 1,4-naphthoquinones structurally related to lapachol.
Bioorganic & medicinal chemistry 2002;10(8):2731-8.
2002: T Gyotoku; F Ono; Laure Aurelian
Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK.
Vaccine 2002;20(21-22):2796-807.
2002: Dana Perkins; YANXING YU; Linda L Bambrick; Paul J Yarowsky; Laure Aurelian
Expression of herpes simplex virus type 2 protein ICP10 PK rescues neurons from apoptosis due to serum deprivation or genetic defects.
Experimental neurology 2002;174(1):118-22.
2002: Dana Perkins; Edna F R Pereira; Michael D Gober; Paul J Yarowsky; Laure Aurelian
The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway.
Journal of virology 2002;76(3):1435-49.
2001: YANXING YU; A Heller; Thomas Liehr; Cynthia C Smith; Laure Aurelian
Expression analysis and chromosome location of a novel gene (H11) associated with the growth of human melanoma cells.
International journal of oncology 2001;18(5):905-11.
2001: M Wachsman; M Kulka; Cynthia C Smith; Laure Aurelian
A growth and latency compromised herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic and therapeutic protective activity in guinea pigs.
Vaccine 2001;19(15-16):1879-90.
2001: Laure Aurelian; Cynthia C Smith; R Winchurch; M Kulka; T Gyotoku; L Zaccaro; F J Chrest; Joseph W Burnett
A novel gene expressed in human keratinocytes with long-term in vitro growth potential is required for cell growth.
The Journal of investigative dermatology 2001;116(2):286-95.
2001: Faisal F Y Radwan; Joseph W Burnett; DA Bloom; T Coliano; ME Eldefrawi; H Erderly; Laure Aurelian; Mónica Torres; Edgar P Heimer-de la Cotera
A comparison of the toxinological characteristics of two Cassiopea and Aurelia species.
Toxicon : official journal of the International Society on Toxinology 2001;39(2-3):245-57.
2000: Cynthia C Smith; J Nelson; Laure Aurelian; Michael D Gober; Biswendu Bikash Goswami
Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth.
Journal of virology 2000;74(22):10417-29.
2000: Cynthia C Smith; M Kulka; Laure Aurelian
Modified adenovirus penton base protein (UTARVE) as a non-replicating vector for delivery of antisense oligonucleotides with antiviral and/or antineoplastic activity.
International journal of oncology 2000;17(4):841-50.
2000: Cynthia C Smith; YANXING YU; M Kulka; Laure Aurelian
A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serine-threonine PK and is expressed in melanoma cells.
The Journal of biological chemistry 2000;275(33):25690-9.
2000: Laure Aurelian; Cynthia C Smith
Herpes simplex virus type 2 growth and latency reactivation by cocultivation are inhibited with antisense oligonucleotides complementary to the translation initiation site of the large subunit of ribonucleotide reductase (RR1).
Antisense & nucleic acid drug development 2000;10(2):77-85.
1999: T Gyotoku; Laure Aurelian; A R Neurath
Cellulose acetate phthalate (CAP): an 'inactive' pharmaceutical excipient with antiviral activity in the mouse model of genital herpesvirus infection.
Antiviral chemistry & chemotherapy 1999;10(6):327-32.
1999: Hisashi Kokuba; Laure Aurelian; Joseph W Burnett
Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions.
The Journal of investigative dermatology 1999;113(5):808-15.
1999: Hisashi Kokuba; Catharine Lisa Kauffman; Joseph W Burnett; Laure Aurelian
Clinical and virological comparison of 3 patients with erythema multiforme.
Acta dermato-venereologica 1999;79(3):247-8.
1999: Laure Aurelian; Hisashi Kokuba; Cynthia C Smith
Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10).
Vaccine 1999;17(15-16):1951-63.
1999: Hisashi Kokuba; Shinichi Imafuku; Joseph W Burnett; Laure Aurelian
Longitudinal study of a patient with herpes-simplex-virus-associated erythema multiforme: viral gene expression and T cell repertoire usage.
Dermatology (Basel, Switzerland) 1999;198(3):233-42.
1998: Cynthia C Smith; T Peng; M Kulka; Laure Aurelian
The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth.
Journal of virology 1998;72(11):9131-41.
1998: Bhuvnesh Kumar Sharma; R Sharma; Cynthia C Smith; Laure Aurelian
Prevalence of serum antibodies to LA-1 oncoprotein, herpes simplex virus type-2 glycoprotein and human papillomavirus type 16 transactivator (E2) protein among Indian women with cervical neoplasia.
Indian journal of experimental biology 1998;36(10):967-72.
1998: Hisashi Kokuba; Laure Aurelian; A R Neurath
3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.
Antiviral chemistry & chemotherapy 1998;9(4):353-7.
1998: Hisashi Kokuba; Shinichi Imafuku; S Huang; Laure Aurelian; Joseph W Burnett
Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response.
The British journal of dermatology 1998;138(6):952-64.
1998: Laure Aurelian
Herpes simplex virus type 2: unique biological properties include neoplastic potential mediated by the PK domain of the large subunit of ribonucleotide reductase.
Frontiers in bioscience : a journal and virtual library 1998;3():d237-49.
1998: Laure Aurelian; Hisashi Kokuba; Joseph W Burnett
Understanding the pathogenesis of HSV-associated erythema multiforme.
Dermatology (Basel, Switzerland) 1998;197(3):219-22.
1997: K L Beasley; G E Cooley; GF Kao; Mark H Lowitt; Joseph W Burnett; Laure Aurelian
Herpes simplex vegetans: atypical genital herpes infection in a patient with common variable immunodeficiency.
Journal of the American Academy of Dermatology 1997;37(5 Pt 2):860-3.
1997: Shinichi Imafuku; Hisashi Kokuba; Laure Aurelian; Joseph W Burnett
Expression of herpes simplex virus DNA fragments located in epidermal keratinocytes and germinative cells is associated with the development of erythema multiforme lesions.
The Journal of investigative dermatology 1997;109(4):550-6.
1997: Cynthia C Smith; Laure Aurelian
The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity.
Virology 1997;234(2):235-42.
1997: J Zhu; Laure Aurelian
AP-1 cis-response elements are involved in basal expression and Vmw110 transactivation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Virology 1997;231(2):301-12.
1996: Joseph W Burnett; DA Bloom; Shinichi Imafuku; H Houck; S Vanucci; Laure Aurelian; S C Morris
Coelenterate venom research 1991-1995: clinical, chemical and immunological aspects.
Toxicon : official journal of the International Society on Toxinology 1996;34(11-12):1377-83.
1996: J W Nelson; J Zhu; Cynthia C Smith; M Kulka; Laure Aurelian
ATP and SH3 binding sites in the protein kinase of the large subunit of herpes simplex virus type 2 of ribonucleotide reductase (ICP10).
The Journal of biological chemistry 1996;271(29):17021-7.
1996: S Miura; Joseph W Burnett; Laure Aurelian
Ultraviolet light and immunity to coelenterate venom.
Cutis; cutaneous medicine for the practitioner 1996;57(4):201-4.
1996: Cynthia C Smith; J H Luo; Laure Aurelian
The protein kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) fused to the extracellular domain of the epidermal growth factor receptor is ligand-inducible.
Virology 1996;217(2):425-34.
1996: C P Feng; M Kulka; Cynthia C Smith; Laure Aurelian
Herpes simplex virus-mediated activation of human immunodeficiency virus is inhibited by oligonucleoside methylphosphonates that target immediate-early mRNAs 1 and 3.
Antisense & nucleic acid drug development 1996;6(1):25-35.
1995: J M Kean; S A Kipp; Paul S Miller; M Kulka; Laure Aurelian
Inhibition of herpes simplex virus replication by antisense oligo-2'-O-methylribonucleoside methylphosphonates.
Biochemistry 1995;34(45):14617-20.
1995: J Hunter; C Smith; Laure Aurelian
The hsv-2 la-1 oncoprotein is a member of a novel family of serine threonine receptor kinases.
International journal of oncology 1995;7(3):515-22.
1995: J C Hunter; Cynthia C Smith; D Bose; M Kulka; R Broderick; Laure Aurelian
Intracellular internalization and signaling pathways triggered by the large subunit of HSV-2 ribonucleotide reductase (ICP10).
Virology 1995;210(2):345-60.
1995: Mathuram Santosham; RICHARD SACK; Raymond Reid; Robert E Black; J Croll; Robert H Yolken; Laure Aurelian; M Wolff; E Chan; S Garrett
Diarrhoeal diseases in the White Mountain Apaches: epidemiologic studies.
Journal of diarrhoeal diseases research 1995;13(1):18-28.
1995: RICHARD SACK; Mathuram Santosham; Raymond Reid; Robert E Black; J Croll; Robert H Yolken; Laure Aurelian; M Wolff; E Chan; S Garrett
Diarrhoeal diseases in the White Mountain Apaches: clinical studies.
Journal of diarrhoeal diseases research 1995;13(1):12-7.
1995: M Kulka; Laure Aurelian
Antiviral activity of an oligo(nucleoside methylphosphonate) that targets HSV-1 immediate-early pre-mRNA 4,5 is augmented by cotreatment with replication-defective adenovirus.
Antisense research and development 1995;5(4):243-9.
1994: S Miura; M Kulka; Cynthia C Smith; Shinichi Imafuku; Joseph W Burnett; Laure Aurelian
Cutaneous ultraviolet radiation inhibits herpes simplex virus-induced lymphoproliferation in latently infected subjects.
Clinical immunology and immunopathology 1994;72(1):62-9.
1994: Cynthia C Smith; J H Luo; J C Hunter; J V Ordonez; Laure Aurelian
The transmembrane domain of the large subunit of HSV-2 ribonucleotide reductase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation.
Virology 1994;200(2):598-612.
1994: M Kulka; Cynthia C Smith; J Levis; R Fishelevich; J C Hunter; C D Cushman; Paul S Miller; PO Ts'o; Laure Aurelian
Synergistic antiviral activities of oligonucleoside methylphosphonates complementary to herpes simplex virus type 1 immediate-early mRNAs 4, 5, and 1.
Antimicrobial agents and chemotherapy 1994;38(4):675-80.
1994: B Sharma; J Nelson; C Smith; Laure Aurelian
Detection of la-1 oncogene in paraffin-embedded cervical-cancer tissues by polymerase chain-reaction.
International journal of oncology 1994;4(1):23-8.
1993: S Miura; Joseph W Burnett; Laure Aurelian
Immunity to jellyfish venoms: suppression of venom-induced immune responses in ultraviolet B-irradiated mice.
Toxicon : official journal of the International Society on Toxinology 1993;31(11):1415-22.
1993: Laure Aurelian
Genital cancer and Langerhans cells.
In vivo (Athens, Greece) 1993;7(3):297-304.
1993: C P Feng; M Kulka; Laure Aurelian
The GGTCA palindrome and cognate cellular factors in trans-regulation of human immunodeficiency virus long terminal repeat by herpes simplex virus.
The Journal of general virology 1993;74 ( Pt 4)():715-23.
1993: M Kulka; M Wachsman; S Miura; R Fishelevich; Paul S Miller; PO Ts'o; Laure Aurelian
Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5.
Antiviral research 1993;20(2):115-30.
1993: C P Feng; M Kulka; Laure Aurelian
NF-kappa B-binding proteins induced by HSV-1 infection of U937 cells are not involved in activation of human immunodeficiency virus.
Virology 1993;192(2):491-500.
1992: PO Ts'o; Laure Aurelian; E Chang; Paul S Miller
Nonionic oligonucleotide analogs (Matagen) as anticodic agents in duplex and triplex formation.
Annals of the New York Academy of Sciences 1992;660():159-77.
1992: Cynthia C Smith; M Kulka; J P Wymer; T D Chung; Laure Aurelian
Expression of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for virus growth and neoplastic transformation.
The Journal of general virology 1992;73 ( Pt 6)():1417-28.
1992: J H Luo; Laure Aurelian
The transmembrane helical segment but not the invariant lysine is required for the kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
The Journal of biological chemistry 1992;267(14):9645-53.
1992: J P Wymer; Colette ApRhys; T D Chung; C P Feng; M Kulka; Laure Aurelian
Immediate early and functional AP-1 cis-response elements are involved in the transcriptional regulation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Virus research 1992;23(3):253-70.
1992: M Wachsman; J H Luo; Laure Aurelian; E Paoletti
Protection from herpes simplex virus type 2 is associated with T cells involved in delayed type hypersensitivity that recognize glycosylation-related epitopes on glycoprotein D.
Vaccine 1992;10(7):447-54.
1992: S Miura; Cynthia C Smith; Joseph W Burnett; Laure Aurelian
Detection of viral DNA within skin of healed recurrent herpes simplex infection and erythema multiforme lesions.
The Journal of investigative dermatology 1992;98(1):68-72.
1991: J H Luo; Cynthia C Smith; M Kulka; Laure Aurelian
A truncated protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) expressed in Escherichia coli.
The Journal of biological chemistry 1991;266(31):20976-83.
1991: Laure Aurelian; Cynthia C Smith; M Wachsman; E Paoletti
Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D.
Reviews of infectious diseases 1991;13 Suppl 11():S924-34.
1991: Cynthia C Smith; J P Wymer; J Luo; Laure Aurelian
Genomic sequences homologous to the protein kinase region of the bifunctional herpes simplex virus type 2 protein ICP10.
Virus genes 1991;5(3):215-26.
1991: T D Chung; J H Luo; J P Wymer; Cynthia C Smith; Laure Aurelian
Leucine repeats in the large subunit of herpes simplex virus type 2 ribonucleotide reductase (RR; ICP10) are involved in RR activity and subunit complex formation.
The Journal of general virology 1991;72 ( Pt 5)():1139-44.
1991: M Wachsman; Laure Aurelian; Joseph W Burnett
Human immunosuppression induced by sea nettle (Chrysaora quinquecirrha) venom.
Toxicon : official journal of the International Society on Toxinology 1991;29(3):386-90.
1991: Laure Aurelian
Viruses and carcinoma of the cervix.
Contributions to gynecology and obstetrics 1991;18():54-70.
1990: S Costa; Antonella Rotola; P Terzano; M G Poggi; Dario Di Luca; Laure Aurelian; Enzo Cassai; C Orlandi
Search for herpes simplex virus 2 and human papillomavirus genetic expression in vulvar neoplasia.
The Journal of reproductive medicine 1990;35(12):1108-12.
1990: T D Chung; J P Wymer; M Kulka; Cynthia C Smith; Laure Aurelian
Myristylation and polylysine-mediated activation of the protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Virology 1990;179(1):168-78.
1990: M Wachsman; Laure Aurelian; Joseph W Burnett
The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections.
The British journal of dermatology 1990;123(3):375-80.
1990: J P Wymer; Laure Aurelian
Papillomavirus trans-activator protein E2 activates expression from the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2.
The Journal of general virology 1990;71 ( Pt 8)():1817-21.
1990: Laure Aurelian; M Wachsman; Joseph W Burnett
Clinical and subclinical HSV infection resulting from exposure to asymptomatic patients.
The British journal of dermatology 1990;122(1):117-9.
1989: M Kulka; Cynthia C Smith; Laure Aurelian; R Fishelevich; K Meade; Paul S Miller; PO Ts'o
Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(18):6868-72.
1989: M Wachsman; J H Luo; Laure Aurelian; M E Perkus; E Paoletti
Antigen-presenting capacity of epidermal cells infected with vaccinia virus recombinants containing the herpes simplex virus glycoprotein D, and protective immunity.
The Journal of general virology 1989;70 ( Pt 9)():2513-20.
1989: T D Chung; J P Wymer; Cynthia C Smith; M Kulka; Laure Aurelian
Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Journal of virology 1989;63(8):3389-98.
1989: J P Wymer; T D Chung; Y N Chang; Gary S Hayward; Laure Aurelian
Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2.
Journal of virology 1989;63(6):2773-84.
1989: M Wachsman; Laure Aurelian; Cynthia C Smith; M E Perkus; E Paoletti
Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.
The Journal of infectious diseases 1989;159(4):625-34.
1988: M Wachsman; Laure Aurelian; J C Hunter; M E Perkus; E Paoletti
Expression of herpes simplex virus glycoprotein D on antigen presenting cells infected with vaccinia recombinants and protective immunity.
Bioscience reports 1988;8(4):323-34.
1988: Laure Aurelian; S Yasumoto; Cynthia C Smith
Antigen-specific immune-suppressor factor in herpes simplex virus type 2 infections of UV B-irradiated mice.
Journal of virology 1988;62(7):2520-4.
1987: Laure Aurelian; C L Rinehart; M Wachsman; M Kulka; PO Ts'o
Augmentation of natural immune defence mechanisms and therapeutic potential of a mismatched double-stranded polynucleotide in cutaneous herpes simplex virus type 2 infection.
The Journal of general virology 1987;68 ( Pt 11)():2831-8.
1987: S Yasumoto; Y Hayashi; Laure Aurelian
Immunity to herpes simplex virus type 2. Suppression of virus-induced immune responses in ultraviolet B-irradiated mice.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(8):2788-93.
1987: Joseph W Burnett; K P Hepper; Laure Aurelian; G J Calton; S F Gardepe
Recurrent eruptions following unusual solitary coelenterate envenomations.
Journal of the American Academy of Dermatology 1987;17(1):86-92.
1987: M Wachsman; Laure Aurelian; Cynthia C Smith; B R Lipinskas; M E Perkus; E Paoletti
Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
The Journal of infectious diseases 1987;155(6):1188-97.
1987: john sheridan; M Beck; Cynthia C Smith; Laure Aurelian
Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(4):1234-9.
1987: PO Ts'o; Paul S Miller; Laure Aurelian; A Murakami; C Agris; K R Blake; S B Lin; B L Lee; Cynthia C Smith
An approach to chemotherapy based on base sequence information and nucleic acid chemistry. Matagen (masking tape for gene expression).
Annals of the New York Academy of Sciences 1987;507():220-41.
1987: E R te Velde; Laure Aurelian
Antibodies to the herpes simplex virus type-2-induced tumor-associated antigen AG-4 as markers of recurrence in cervical cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1987;8(1):26-33.
1987: S Costa; A D'Errico; Walter Franco Grigioni; C Orlandi; Cynthia C Smith; A M Mancini; Laure Aurelian
Monoclonal antibody to HSV2 protein as an immunodiagnostic marker in cervical cancer.
Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc 1987;1():189-205.
1986: Cynthia C Smith; Laure Aurelian; M P Reddy; Paul S Miller; PO Ts'o
Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(9):2787-91.
1986: Y Hayashi; Laure Aurelian
Immunity to herpes simplex virus type 2: viral antigen-presenting capacity of epidermal cells and its impairment by ultraviolet irradiation.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(3):1087-92.
1986: S Costa; Cynthia C Smith; S Taylor; Laure Aurelian; C Orlandi
Intracellular localization and serological identification of a HSV-2 protein in cervical cancer.
European journal of gynaecological oncology 1986;7(1):1-12.
1986: Joseph W Burnett; K P Hepper; Laure Aurelian
Lymphokine activity in coelenterate envenomation.
Toxicon : official journal of the International Society on Toxinology 1986;24(1):104-7.
1985: Y Hayashi; T Iwasaka; Cynthia C Smith; Laure Aurelian; George K Lewis; P O Ts'o
Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene product.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(24):8493-7.
1985: T Iwasaka; Cynthia C Smith; Laure Aurelian; P O Ts'o
The cervical tumor-associated antigen (ICP-10/AG-4) is encoded by the transforming region of the genome of herpes simplex virus type 2.
Japanese journal of cancer research : Gann 1985;76(10):946-58.
1985: john sheridan; M Beck; Laure Aurelian; M Radowsky
Immunity to herpes simplex virus: virus reactivation modulates lymphokine activity.
The Journal of infectious diseases 1985;152(3):449-56.
1985: Paul S Miller; C H Agris; Laure Aurelian; K R Blake; A Murakami; M P Reddy; S A Spitz; PO Ts'o
Control of ribonucleic acid function by oligonucleoside methylphosphonates.
Biochimie 1985;67(7-8):769-76.
1984: john sheridan; Laure Aurelian; A D Donnenberg; Thomas C Quinn
Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses.
Journal of clinical immunology 1984;4(4):304-11.
1984: Laure Aurelian
Herpes simplex virus type 2 and cervical cancer.
Clinics in dermatology 1984;2(2):90-9.
1984: john sheridan; Cynthia C Smith; M M Manak; Laure Aurelian
Prevention of rotavirus-induced diarrhea in neonatal mice born to dams immunized with empty capsids of simian rotavirus SA-11.
The Journal of infectious diseases 1984;149(3):434-8.
1984: john sheridan; Laure Aurelian; Thomas C Quinn
Modulation of virus-specific immunity in vitro by the addition of interleukin-1 and interleukin-2 in patients with the acquired immune deficiency syndrome.
Annals of the New York Academy of Sciences 1984;437():530-4.
1983: T Iwasaka; john sheridan; Laure Aurelian
Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors.
Infection and immunity 1983;42(3):955-64.
1983: R J Jariwalla; Laure Aurelian; P O Ts'o
Immortalization and neoplastic transformation of normal diploid cells by defined cloned DNA fragments of herpes simplex virus type 2.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(19):5902-6.
1983: Cynthia C Smith; Laure Aurelian; Mathuram Santosham; RICHARD SACK
Rotavirus-associated traveler's diarrhea: neutralizing antibody in asymptomatic infections.
Infection and immunity 1983;41(2):829-33.
1983: john sheridan; R S Eydelloth; S L Vonderfecht; Laure Aurelian
Virus-specific immunity in neonatal and adult mouse rotavirus infection.
Infection and immunity 1983;39(2):917-27.
1983: Laure Aurelian; Cynthia C Smith; K T Klacsman; P K Gupta; J K Frost
Expression and cellular compartmentalization of a herpes simplex virus type 2 protein (ICP 10) in productively infected and cervical tumor cells.
Cancer investigation 1983;1(4):301-13.
1983: john sheridan; Laure Aurelian
Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
Diagnostic immunology 1983;1(3):245-56.
1982: john sheridan; A D Donnenberg; Laure Aurelian; D J Elpern
Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(1):326-31.
1982: Laure Aurelian
Herpes simplex virus diagnosis. Antigen detection by ELISA and flow microfluorometry.
Diagnostic gynecology and obstetrics 1982;4(4):375-88.
1981: Laure Aurelian; M M Manak; M McKinlay; Cynthia C Smith; K T Klacsmann; P K Gupta
"The Herpesvirus hypothesis"--are Koch's postulates satisfied?
Gynecologic oncology 1981;12(2 Pt 2):S56-87.
1981: P K Gupta; Laure Aurelian; J K Frost; J M Carpenter; K T Klacsmann; N B Rosenshein; Harry W Tyrer
Herpesvirus antigens as markers for cervical cancer.
Gynecologic oncology 1981;12(2 Pt 2):S232-58.
1981: M M Manak; Laure Aurelian; P O Ts'o
Focus formation and neoplastic transformation by herpes simplex virus type 2 inactivated intracellularly by 5-bromo-2'-deoxyuridine and near UV light.
Journal of virology 1981;40(1):289-300.
1981: Cynthia C Smith; P K Gupta; Laure Aurelian
Expression of herpesvirus-induced antigens in human cervical cancer.
Nature 1981;292(5821):388-9.
1981: Laure Aurelian; I I Kessler; N B Rosenshein; G Barbour
Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
Cancer 1981;48(2 Suppl):455-71.
1981: john sheridan; Laure Aurelian; G Barbour; Mathuram Santosham; RICHARD SACK; Robert W Ryder
Traveler's diarrhea associated with rotavirus infection: analysis of virus-specific immunoglobulin classes.
Infection and immunity 1981;31(1):419-29.
1980: A D Donnenberg; R B Bell; Laure Aurelian
Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.
Cellular immunology 1980;56(2):526-39.
1980: A D Donnenberg; Elliot L Chaikof; Laure Aurelian
Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.
Infection and immunity 1980;30(1):99-109.
1980: Cynthia C Smith; Laure Aurelian; P K Gupta; J K Frost; N B Rosenshein; K Klacsmann; S Geddes
An evaluation of herpes simplex virus antigenic markers in the study of established and developing cervical neoplasia.
Analytical and quantitative cytology 1980;2(2):131-43.
1980: R J Jariwalla; Laure Aurelian; P O Ts'o
Tumorigenic transformation induced by a specific fragment of DNA from herpes simplex virus type 2.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(4):2279-83.
1979: Laure Aurelian; Harry W Tyrer; P K Gupta; J K Frost; L A Adams; S M Tiffany
Microfluorometric quantitation of size, deoxyribonucleic acid and viral antigenic determinants in cells productively infected with HSV-2.
Analytical and quantitative cytology 1979;1(3):207-16.
1979: Cynthia C Smith; Laure Aurelian
Proteins of herpesvirus type 2. V. Isolation and immunologic characterization of two viral proteins in a virus-specific antigenic fraction.
Virology 1979;98(1):255-60.
1979: Laure Aurelian; P K Gupta; J K Frost; N B Rosenshein; Cynthia C Smith; Harry W Tyrer; J M Mantione; Craig D Albright
Fluorescence-activated separation of cervical abnormal cells using herpesvirus antigenic markers.
Analytical and quantitative cytology 1979;1(2):89-102.
1979: J D Small; Laure Aurelian; Robert A. Squire; J D Strandberg; E C Melby; T B Turner; B Newman
Rabbit cardiomyopathy associated with a virus antigenically related to human coronavirus strain 229E.
The American journal of pathology 1979;95(3):709-29.
1979: R J Jariwalla; Laure Aurelian; P O Ts'o
Neoplastic transformation of cultured Syrian hamster embryo cells by DNA of herpes simplex virus type 2.
Journal of virology 1979;30(1):404-9.
1978: R B Bell; Laure Aurelian; G H Cohen
Proteins of herpes virus type 2 IV. Leukocyte inhibition responses to type common antigen(s) in cervix cancer and recurrent herpetic infections.
Cellular immunology 1978;41(1):86-102.
1978: T Kawana; S Sakamoto; T Kasamatsu; Laure Aurelian
Frequency of anti-AG-4 antibody in patients with uterine cervical cancer and controls.
Gann = Gan 1978;69(4):589-91.
1978: B C Strnad; Laure Aurelian
Proteins of herpesvirus type 2. III. Isolation and immunologic characterization of a large molecular weight viral protein.
Virology 1978;87(2):401-15.
1978: B C Strnad; M F Smith; Laure Aurelian
Studies demonstrating the immunological identity of the tumour-associated antigen AG-4 with a virion envelope protein.
IARC scientific publications 1978;(24 Pt 1):203-13.
1977: Laure Aurelian; B C Strnad; M F Smith
Immunodiagnostic potential of a virus-coded, tumor-associated antigen (AG-4) in cervical cancer.
Cancer 1977;39(4 Suppl):1834-49.
1976: B C Strnad; Laure Aurelian
Proteins of herpesvirus type 2. II. Studies demonstrating a correlation between a tumor-associated antigen (AG-4) and a virion protein.
Virology 1976;73(1):244-58.
1976: T Kawana; J D Cornish; M F Smith; Laure Aurelian
Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
Cancer research 1976;36(6):1910-4.
1976: R P Jacobs; Laure Aurelian; G A Cole
Cell-mediated immune response to herpes simplex virus: type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection.
Journal of immunology (Baltimore, Md. : 1950) 1976;116(6):1520-5.
1976: Laure Aurelian; M F Smith; D J Cornish
IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells.
Journal of the National Cancer Institute 1976;56(3):471-7.
1976: Laure Aurelian
Sexually transmitted cancers? The case for genital herpes.
Journal of the American Venereal Disease Association 1976;2(3):10-20.
1976: B C Strnad; Laure Aurelian
Proteins of herpesvirus type 2: I. Virion, nonvirion, and antigenic polypeptides in infected cells.
Virology 1976;69(2):438-52.
1976: Laure Aurelian; B C Strnad
Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer.
Cancer research 1976;36(2 pt 2):810-20.
1975: Laure Aurelian; J D Cornish; M F Smith
Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
IARC scientific publications 1975;(11 Pt 2):79-87.
1974: Laure Aurelian
The "viruses of love" and cancer.
The American journal of medical technology 1974;40(11):496-512.
1974: Laure Aurelian
Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
Cancer research 1974;34(5):1126-35.
1974: Laure Aurelian; S Smerdel; I I Kessler; Z Kulcar
Three Yugoslav herpes simplex viruses: biologic and antigenic properties and formation of giant cells in vitro by a cervical isolate.
The Journal of infectious diseases 1974;129(4):465-9.
1974: Laure Aurelian
Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
Clinical orthopaedics and related research 1974;(99):78-85.
1974: Laure Aurelian; J D Strandberg; R L Marcus
Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
Progress in experimental tumor research 1974;19():165-81.
1974: Laure Aurelian; J D Strandberg
Biologic and immunologic comparison of two HSV-2 variants: one an isolate from cervical tumor cells.
Archiv für die gesamte Virusforschung 1974;45(1-2):27-38.
1973: Laure Aurelian; B Schumann; R L Marcus; H J Davis
Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma.
Science (New York, N.Y.) 1973;181(4095):161-4.
1973: Laure Aurelian; H J Davis; C G Julian
Herpesvirus type 2-induced, tumor-specific antigen in cervical carcinoma.
American journal of epidemiology 1973;98(1):1-9.
1973: Laure Aurelian
Virions and antigens of herpes virus type 2 in cervical carcinoma.
Cancer research 1973;33(6):1539-47.
1973: Laure Aurelian
Herpesvirus hominis: from latency to carcinogenesis?
Johns Hopkins medical journal. Supplement 1973;2():245-66.
1972: Laure Aurelian
Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
Federation proceedings 1972;31(6):1651-9.
1972: Laure Aurelian; J D Strandberg; H J Davis
HSV-2 antigens absent from biopsied cervical tumor cells: a model consistent with latency.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1972;140(2):404-8.
1971: Laure Aurelian; J D Strandberg; L V Melendez; L A Johnson
Herpesvirus type 2 isolated from cervical tumor cells grown in tissue culture.
Science (New York, N.Y.) 1971;174(4010):704-7.
1970: Laure Aurelian; I Royston; H J Davis
Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ.
Journal of the National Cancer Institute 1970;45(3):455-64.
1970: I Royston; Laure Aurelian
Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 1970;67(1):204-12.
1970: I Royston; Laure Aurelian
The association of genital herpesvirus with cervical atypia and carcinoma in situ.
American journal of epidemiology 1970;91(6):531-8.
1970: I Royston; Laure Aurelian; H J Davis
Genital herpes virus findings in relation to cervical neoplasia.
The Journal of reproductive medicine 1970;4(4):9-13.
1969: J D Strandberg; Laure Aurelian
Replication of canine herpesvirus. II. Virus development and release in infected dog kidney cells.
Journal of virology 1969;4(4):480-9.
1969: Laure Aurelian
Replication of canine herpesvirus: I. Synthesis of viral deoxyribonucleic Acid.
Journal of virology 1969;4(3):197-202.
1969: Laure Aurelian
Factors affecting the growth of canine herpesvirus in dog kidney cells.
Applied microbiology 1969;17(1):179-81.
1968: Laure Aurelian
Effect of environmental conditions on formation and release of canine herpesvirus in infected canine kidney cells.
American journal of veterinary research 1968;29(10):1945-52.
1968: Laure Aurelian
Demonstration by plaque reduction technique of immunologic relationship between canine herpes virus and herpes simplex virus.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1968;127(2):485-8.
1966: A Taktikos; Laure Aurelian
Experimental study of the disease of the corneal stroma caused by herpes simplex virus.
American journal of ophthalmology 1966;62(6):1136-41.
1966: Laure Aurelian; R R Wagner
Two populations of herpes virus virions which appear to differ in physical properties and DNA composition.
Proceedings of the National Academy of Sciences of the United States of America 1966;56(3):902-9.
1965: Laure Aurelian; B ROIZMAN
ABORTIVE INFECTION OF CANINE CELLS BY HERPES SIMPLEX VIRUS. II. ALTERNATIVE SUPPRESSION OF SYNTHESIS OF INTERFERON AND VIRAL CONSTITUENTS.
Journal of molecular biology 1965;11():539-48.
1965: B ROIZMAN; Laure Aurelian
ABORTIVE INFECTION OF CANINE CELLS BY HERPES SIMPLEX VIRUS. I. CHARACTERIZATION OF VIRAL PROGENY FROM CO-OPERATIVE INFECTION WITH MUTANTS DIFFERING IN CAPACITY TO MULTIPLY IN CANINE CELLS.
Journal of molecular biology 1965;11():528-38.
1964: Laure Aurelian; B ROIZMAN
THE HOST RANGE OF HERPES SIMPLEX VIRUS; INTERFERON, VIRAL DNA, AND ANTIGEN SYNTHESIS IN ABORTIVE INFECTION OF DOG KIDNEY CELLS.
Virology 1964;22():452-61.
1963: B ROIZMAN; Laure Aurelian; P R ROANE
THE MULTIPLICATION OF HERPES SIMPLEX VIRUS. I. THE PROGRAMMING OF VIRAL DNA DUPLICATION IN HEP-2 CELLS.
Virology 1963;21():482-98.